{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:31:30Z","timestamp":1786570290637,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.compbiomed.2026.111785","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:59:40Z","timestamp":1780491580000},"page":"111785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Network pharmacology, molecular docking, and dynamics simulation of 7-phenyl-5-(p-tolyl)pyrido[2,3-d] pyrimidine-4-amine as anticancer agents with multitarget inhibitory action"],"prefix":"10.1016","volume":"213","author":[{"given":"Boutaina","family":"Addoum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Chebaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soukayna","family":"Baammi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsane","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Drissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Bourhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"chaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"El Mzibri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Attaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Dakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhakim","family":"Elmakssoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Benbacer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2026.111785_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.compbiomed.2026.111785_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114806","article-title":"New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis","volume":"163","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiomed.2026.111785_bib3","first-page":"129","article-title":"Cancer biomarkers - current perspectives","volume":"132","author":"Bhatt","year":"2010","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.compbiomed.2026.111785_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.phrs.2015.09.019","article-title":"Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs","volume":"102","author":"Tao","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.compbiomed.2026.111785_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.seminoncol.2012.08.008","article-title":"Prognostic value of cell-cycle regulation biomarkers in bladder cancer","volume":"39","author":"Mitra","year":"2012","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.compbiomed.2026.111785_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/cancers11040490","article-title":"Targeting tyrosine kinases in cancer: lessons for an effective targeted therapy in the clinic","volume":"11","author":"Angelucci","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.compbiomed.2026.111785_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2017.06.006","article-title":"Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies \u2013 a review","volume":"8","author":"Al-Abd","year":"2017","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.compbiomed.2026.111785_bib8","doi-asserted-by":"crossref","first-page":"18872","DOI":"10.1021\/acsomega.0c02038","article-title":"Dual targeting of VEGFR2 and C-Met kinases via the design and synthesis of substituted 3-(Triazolo-thiadiazin-3-yl)indolin-2-one derivatives as angiogenesis inhibitors","volume":"5","author":"Mohamady","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiomed.2026.111785_bib9","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3748\/wjg.14.2487","article-title":"Effect and mechanism of the twist gene on invasion and metastasis of gastric carcinoma cells","volume":"14","author":"Luo","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.compbiomed.2026.111785_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/cancers12010093","article-title":"PIK3CA gene mutations in solid malignancies: association with clinicopathological parameters and prognosis","volume":"12","author":"Alqahtani","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.compbiomed.2026.111785_bib11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bmcl.2008.01.054","article-title":"Development of pyridopyrimidines as potent Akt1\/2 inhibitors","volume":"18","author":"Wu","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.compbiomed.2026.111785_bib12","author":"Founini"},{"key":"10.1016\/j.compbiomed.2026.111785_bib13","doi-asserted-by":"crossref","first-page":"244ra91","DOI":"10.1126\/scitranslmed.3008970","article-title":"EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype","volume":"6","author":"Rebouissou","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.compbiomed.2026.111785_bib14","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1080\/08927022.2018.1515484","article-title":"Targeting epidermal growth factor receptors inhibition in non-small-cell lung cancer: a computational approach","volume":"44","author":"Patel","year":"2018","journal-title":"Mol. Simul."},{"key":"10.1016\/j.compbiomed.2026.111785_bib15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/diagnostics13081471","article-title":"The evaluation of vascular endothelial growth factor A (VEGFA) and VEGFR2 receptor as prognostic biomarkers in bladder cancer","volume":"13","author":"El Azzouzi","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.compbiomed.2026.111785_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.33263\/BRIAC146.149","article-title":"Computational insights into VEGFR1 inhibitors: redefining cancer treatment through dual-targeted therapy","volume":"14","author":"Addoum","year":"2024","journal-title":"Biointerface Res. Appl. Chem."},{"key":"10.1016\/j.compbiomed.2026.111785_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2024.06.024","article-title":"Comprehensive behavioural assessment of TERT in bladder cancer","volume":"42","author":"El Azzouzi","year":"2024","journal-title":"Urol. Oncol.: Seminars and Original Investigations"},{"key":"10.1016\/j.compbiomed.2026.111785_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.36922\/ejmo.7111","article-title":"Lung cancer in Morocco: EGFR and PIK3CA mutations as therapeutic targets and the lack of HER2 mutations","volume":"9","author":"Founini","year":"2025","journal-title":"Eurasian Journal of Medicine and Oncology"},{"key":"10.1016\/j.compbiomed.2026.111785_bib19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.bjc.6603533","article-title":"Expression of twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients","volume":"96","author":"Hosono","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.compbiomed.2026.111785_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1476-4598-3-28","article-title":"A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines","volume":"3","author":"Lind","year":"2004","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.compbiomed.2026.111785_bib21","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/biom11111670","article-title":"Multi-Target in Silico prediction of inhibitors for mitogen-activated protein kinase-interacting kinases","volume":"11","author":"Halder","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.compbiomed.2026.111785_bib22","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1038\/s41467-024-47120-y","article-title":"De novo generation of multi-target compounds using deep generative chemistry","volume":"15","author":"Munson","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2026.111785_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1101007","article-title":"Editorial: drug repurposing and polypharmacology: a synergistic approach in multi-target based drug discovery","volume":"13","author":"Rudrapal","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111785_bib24","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1039\/D3RA00056G","article-title":"Medicinal chemistry perspective of pyrido[2,3- d ]pyrimidines as anticancer agents","volume":"13","author":"Kumar","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2026.111785_bib25","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/ph15101262","article-title":"Identification of novel cyanopyridones and Pyrido[2,3-d]Pyrimidines as anticancer agents with dual VEGFR-2\/HER-2 inhibitory action: synthesis, biological evaluation and molecular docking studies","volume":"15","author":"Al-Warhi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiomed.2026.111785_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejmech.2015.03.029","article-title":"Recent advances in the chemistry and biology of pyridopyrimidines","volume":"95","author":"Buron","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111785_bib27","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4155\/fmc-2023-0149","article-title":"Design, synthesis and biological evaluation of novel selective PI3K\u03b4 inhibitors containing pyridopyrimidine scaffold","volume":"15","author":"Ma","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.compbiomed.2026.111785_bib28","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/ph18101472","article-title":"Innovative amino-functionalization of Pyrido[2,3-d]pyrimidine scaffolds for broad therapeutic applications supported by computational analyses","volume":"18","author":"El-Hema","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiomed.2026.111785_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2025.134608","article-title":"Friedl\u00e4nder reactions for annulated pyrido[2,3-d]pyrimidines: synthesis, structure characterization, anticancer and computational studies","volume":"178","author":"Badran","year":"2025","journal-title":"Tetrahedron"},{"key":"10.1016\/j.compbiomed.2026.111785_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2026.135318","article-title":"Novel Pyrido[2,3-d]pyrimidine derivatives as potential EGFR inhibitors: synthesis and in silico studies","volume":"197","author":"Garmabi","year":"2026","journal-title":"Tetrahedron"},{"key":"10.1016\/j.compbiomed.2026.111785_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytol.2025.104105","article-title":"Harnessing phytoconstituents to treat COVID-19 triggered acute respiratory distress syndrome: insights from network pharmacology, and molecular modeling","volume":"71","author":"Gupta","year":"2026","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.compbiomed.2026.111785_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12906-021-03265-7","article-title":"Validating potent anti-inflammatory and anti-rheumatoid properties of Drynaria quercifolia rhizome methanolic extract through in vitro, in vivo, in silico and GC-MS-based profiling","volume":"21","author":"Modak","year":"2021","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.compbiomed.2026.111785_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112081","article-title":"Study on the potential nephrotoxicity and mutagenicity of aristolochic acid IVa and its mechanism","volume":"142","author":"Xian","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiomed.2026.111785_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.69998\/jnesmp.v2i1.39","article-title":"\u03949-Tetrahydrocannabinol and morphine as potential modulators of STAT3 and IL-6 in ischemic stroke: a case Study and in Silico approaches","volume":"2","author":"Hoummani","year":"2025","journal-title":"Journal of Nursing, Education Sciences, and Medical Practice"},{"key":"10.1016\/j.compbiomed.2026.111785_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.69998\/jnesmp.v1i1.33","article-title":"Rare cardiotoxicity in a child following accidental alphachloralose ingestion: a case Study with In-Silico insights","volume":"1","author":"Hoummani","year":"2024","journal-title":"Journal of Nursing, Education Sciences, and Medical Practice"},{"key":"10.1016\/j.compbiomed.2026.111785_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2026.111785_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.compbiomed.2026.111785_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4213","article-title":"RCSB Protein Data bank: tools for visualizing and understanding biological macromolecules in 3D","volume":"31","author":"Burley","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.compbiomed.2026.111785_bib39","doi-asserted-by":"crossref","first-page":"W478","DOI":"10.1093\/nar\/gku377","article-title":"Enhancing UCSF Chimera through web services","volume":"42","author":"Huang","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2026.111785_bib40","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2147\/IJN.S231062","article-title":"Synthesis, characterization, biomedical application, molecular dynamic simulation and molecular docking of schiff base complex of Cu(II) supported on Fe3O4\/SiO2\/APTS","volume":"15","author":"Eshaghi Malekshah","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.compbiomed.2026.111785_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1288652","article-title":"Potent VEGFR-2 inhibitors for resistant breast cancer: a comprehensive 3D-QSAR, ADMET, molecular docking and MMPBSA calculation on triazolopyrazine derivatives","volume":"10","author":"Baammi","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.compbiomed.2026.111785_bib42","doi-asserted-by":"crossref","DOI":"10.1021\/ja204075s","article-title":"Computer Review of ChemDraw Ultra 12.0","volume":"133","author":"Cousins","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.compbiomed.2026.111785_bib43","doi-asserted-by":"crossref","DOI":"10.1517\/17460441.2010.484460","article-title":"Virtual screening with AutoDock: theory and practice","author":"Cosconati","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.compbiomed.2026.111785_bib44","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/ph17070862","article-title":"Phytochemical analysis and evaluation of antioxidant and antimicrobial properties of essential oils and seed extracts of Anethum graveolens from Southern Morocco: in vitro and in Silico approach for a natural alternative to synthetic preservatives","volume":"17","author":"Hadi","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiomed.2026.111785_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1227643","article-title":"Unleashing Nature's potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET analysis, molecular dynamics, and MMPBSA calculations","volume":"10","author":"Baammi","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.compbiomed.2026.111785_bib46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and autodock\/vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.compbiomed.2026.111785_bib47","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1080\/07391102.2020.1736159","article-title":"Understanding the mechanism of amygdalin's multifunctional anti-cancer action using computational approach","volume":"39","author":"Al-Khafaji","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2026.111785_bib48","article-title":"Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.compbiomed.2026.111785_bib49","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2026.111785_bib50","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.compbiomed.2026.111785_bib51","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1080\/07391102.2021.1872418","article-title":"Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study","volume":"40","author":"Mahmoudi Gomari","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2026.111785_bib52","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/s41598-023-28246-3","article-title":"In silico protein engineering shows that novel mutations affecting NAD+ binding sites may improve phosphite dehydrogenase stability and activity","volume":"13","author":"Baammi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2026.111785_bib53","doi-asserted-by":"crossref","first-page":"W168","DOI":"10.1093\/nar\/gkad393","article-title":"Enrichr-KG: bridging enrichment analysis across multiple libraries","volume":"51","author":"Evangelista","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2026.111785_bib54","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2026.111785_bib55","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.compbiomed.2026.111785_bib56","article-title":"Network pharmacology analysis and clinical efficacy study of fuzi lizhong decoction combined with XELOX plus sintilimab in the treatment of advanced gastric cancer","volume":"104","author":"Zhang","year":"2025","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.compbiomed.2026.111785_bib57","first-page":"948","article-title":"Indonesia herbal medicine and its active compounds for anti-diabetic treatment: a systematic mini review","volume":"11","author":"Fajriyah","year":"2023","journal-title":"Moroc. J. Chem."},{"key":"10.1016\/j.compbiomed.2026.111785_bib59","doi-asserted-by":"crossref","DOI":"10.1080\/10408398.2022.2152423","article-title":"Unveiling toxicity profile for food risk components: a manually curated toxicological databank of food-relevant chemicals","author":"Shi","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.compbiomed.2026.111785_bib60","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3390\/ijms23031771","article-title":"Molecular docking and molecular dynamics simulations discover curcumin analogue as a plausible dual inhibitor for SARS-CoV-2","volume":"23","author":"Rampogu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2026.111785_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128933","article-title":"An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2","volume":"346","author":"Sharma","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.compbiomed.2026.111785_bib62","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.3390\/molecules26237192","article-title":"Insights into the ligand binding to bromodomain-containing protein 9 (BRD9): a guide to the selection of potential binders by computational methods","volume":"26","author":"De Vita","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2026.111785_bib63","doi-asserted-by":"crossref","first-page":"13646","DOI":"10.1080\/07391102.2023.2212304","article-title":"In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies","volume":"41","author":"Moussaoui","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2026.111785_bib64","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ijbiomac.2022.11.227","article-title":"Structural evolution of Delta lineage of SARS-CoV-2","volume":"226","author":"Gomari","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.compbiomed.2026.111785_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2025.100220","article-title":"Leveraging network pharmacology for drug discovery: integrative approaches and emerging insights","volume":"27","author":"Li","year":"2025","journal-title":"Medicine in Drug Discovery"},{"key":"10.1016\/j.compbiomed.2026.111785_bib66","doi-asserted-by":"crossref","first-page":"49399","DOI":"10.1039\/D5RA04875C","article-title":"Integrative network pharmacology and molecular dynamics analysis of Ceiba pentandra compounds with experimental support for colorectal cancer therapy","volume":"15","author":"Suriyakanthan","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2026.111785_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1703562","article-title":"Integrated network pharmacology and experimental verification to reveal the mechanisms of curcumin in the treatment of colorectal cancer","volume":"16","author":"Yuan","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111785_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1708030","article-title":"Network pharmacology analysis and experimental validation to explore the anti-inflammatory mechanism of asiatic acid on alcoholic steatohepatitis","volume":"2022","author":"Jiang","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.compbiomed.2026.111785_bib69","doi-asserted-by":"crossref","DOI":"10.34172\/bi.2023.29951","article-title":"Thiazolo-pyridopyrimidines: an in silico evaluation as a lead for CDK4\/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines","volume":"14","author":"Shetty","year":"2024","journal-title":"Bioimpacts"},{"key":"10.1016\/j.compbiomed.2026.111785_bib70","doi-asserted-by":"crossref","first-page":"11098","DOI":"10.1039\/D4RA00902A","article-title":"Synthesis of novel bioactive pyrido[2,3- d ]pyrimidine derivatives with potent cytotoxicity through apoptosis as PIM-1 kinase inhibitors","volume":"14","author":"Tantawy","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2026.111785_bib71","doi-asserted-by":"crossref","DOI":"10.25259\/AJC_159_2024","article-title":"Computational design of quinazolin-4(3H)-one derivatives as multitarget inhibitors against angiogenesis and metabolic reprogramming to help overcome cancer resistance","volume":"18","author":"Baammi","year":"2025","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.compbiomed.2026.111785_bib73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/012772574X274566231220051254","article-title":"Role of phytoconstituents in cancer treatment: a review","volume":"15","author":"Kumar","year":"2024","journal-title":"Recent Adv Food Nutr Agric"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482526003495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482526003495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:08:29Z","timestamp":1786568909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482526003495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":71,"alternative-id":["S0010482526003495"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111785","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network pharmacology, molecular docking, and dynamics simulation of 7-phenyl-5-(p-tolyl)pyrido[2,3-d] pyrimidine-4-amine as anticancer agents with multitarget inhibitory action","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111785"}}